Connect with us

Spread & Containment

Global COVID-19 Deaths Top 900,000; Europe Daily Tally Tops US For First Time In Months: Live Updates

Global COVID-19 Deaths Top 900,000; Europe Daily Tally Tops US For First Time In Months: Live Updates

Published

on

Global COVID-19 Deaths Top 900,000; Europe Daily Tally Tops US For First Time In Months: Live Updates Tyler Durden Thu, 09/10/2020 - 10:09

Summary:

  • Europe daily tally passes US for first time in months
  • Global deaths top 900k
  • China confirms another reinfected patient
  • Europe cases top 4.6 million as outbreak worsens
  • India reports another record daily case total with 95k+
  • Victoria state sees another daily decline

* * *

Update (0950ET): The number of new COVID-19 cases reported in Europe over the last 24 hours has surpassed the US for the first time

The 27 countries in the European Union plus the U.K., Norway, Iceland and Liechtenstein recorded 27,233 new cases on Wednesday, compared with 26,015 for the US, according to the latest tallies from JHU. It comes as Spain, France and - to a lesser degree, Italy and the UK - lead a resurgence as more businesses and schools reopen.

* * *

Yet another case of COVID-19 reinfection has been confirmed Thursday after a man who traveled from the US to the eastern Chinese city of Nanjing reportedly tested positive for the coronavirus, after two negative tests in less than a month, the local government said.

The man was confirmed as infected on Sept. 9, and had been previously tested twice since his Aug. 11 arrival. The individual has been described as asymtpomatic.

Of course, we've reported on new research suggesting that "dead" virus RNA can trigger positive tests. But if the previously infected can trip tests months later, even after testing negative, that could raise new and uncomfortable questions about global infection tallies, while also offering some insight into the decline in global deaths

On Thursday, China reported seven new cases for the past 24 hours, up from just two a day earlier. All of the new cases were described as imported, including the case mentioned above, since they all allegedly involved travelers from overseas. China has gone 25 consecutive days with no local transmissions. Though South Korea raised important questions about China's numbers earlier this week.

A few weeks ago, Hong Kong confirmed the first case of reinfection anywhere in the wold. Since then, others have been confirmed in Asia and Europe.

In other news, Australia's state of Victoria reported 51 new cases and seven deaths from the virus, compared with 76 cases and 11 deaths a day earlier, in the latest sign that the outbreak is finally waning.

Once again, India reported a record single-day spike in cases and fatalities, with 95,735 infections and 1,172 deaths in the last 24 hours, bringing its COVID-19 total to more than 4.46 million and extending its lead over Brazil.

India's death toll topped 75k, though it's still well behind the 100k+ deaths recorded in Brazil.

In Europe, confirmed coronavirus cases have surpassed 4.6 million, according the WHO. The UK and 13 EU member states are currently "experiencing larger outbreaks of local transmission defined through an assessment of factors including, but not limited to: large numbers of cases not linkable to transmission chains; large numbers of cases from sentinel lab surveillance; and/or multiple unrelated clusters in several areas of the country/territory/area," the WHO said in a statement.

The global COVID-19 rally reached 27,719,952 cases on Thursday....

....while the global death toll topped 901,050, the latest in a series of grim milestones. Forecasts from IHME, an organization affiliated with the University of Washington, has the world on track for 2.8 million deaths by January.

Though many critics have scoffed at these numbers, since a surge of new cases in Europe has seen far fewer deaths than the first wave.

Read More

Continue Reading

Spread & Containment

Beloved regional retailer files Chapter 11 bankruptcy

The company will be closing some stores as it fights to survive in a tough retail environment.

Published

on

The covid pandemic hurt a lot of retailers. In some cases, that was a short-term thing. Customers could not visit during the lockdown periods and that forced people to shop elsewhere.

In some segments, we thought that just because covid forced people to change their behavior did not mean that those changes were permanent. That was a lesson learned by companies like Peloton which saw a boom during the darkest "stay at home" covid days.

People like working out in gyms and it turned out that once it became safe to be in public places crowded with people, the demand for Peloton dropped too. That was true for streaming services as well. 

When we were all stuck at home any new programming was valuable. But as the world opened back up, many Americans realized that they may want some streaming services, but they no longer needed to pay for all of them.

In some cases, people's behavior did permanently change. Americans, for example, are much less willing to go to a movie theater. That seems like an acceleration of a trend that started before the covid pandemic. Watching movies at home showed us that, aside from big blockbusters or Taylor Swift concert movies designed to be a communal experience, most films did not need to be seen in a theater.

Covid also forced a lot of diehard book fans to consider their digital options. Many people who had argued for the joy of holding a physical book realized that being able to download any book to their phone from anywhere had its pluses as well.

That's not good news for bookstores and one popular regional chain has filed for bankruptcy and plans to close some of its stores.

Bookstores struggled during the pandemic because many had to close for weeks or even months. 

Image source: Benedikt Geyer from Pixabay

Regional bookstore chain declares bankruptcy      

While for a time it seemed like digital books would make printed books obsolete, that has not happened. Actual books actually still outsell their digital counterparts, but any e-book sold is a book not sold by a bookstore.

And while some regional bookstore chains have thrived and even Barnes & Noble has found its footing, selling books is a very tough business. Digital books are cheaper than printed books which makes many people visiting bookstores browsers who intend to purchase elsewhere.

That's a very tough operating environment. One regional bookstore chain, Tattered Cover, has filed for reorganization under Chapter 11 Subchapter V in the U.S. Bankruptcy Court for the District of Colorado. The company "owes more than $1 million to publishers, as well as more than $375,000 to Colorado's Office of the State Auditor for abandoned gift cards," Publisher's Weekly reported.

Subchapter V is specifically for small businesses. Tattered Cover believes it can use the filing to obtain new funding up to $1 million from a new company formed by investors and some of its current board. 

That money would be a lifeline, allowing Tattered Cover, which operates seven locations, to purchase inventory for the upcoming holiday season among other uses," according to a company statement.

The chain expects to close three of its bookstores as part of the restructuring.

“Our objective is to put Tattered Cover on a smaller, more modern and financially sustainable platform that will ensure our ability to serve Colorado readers for many more decades,” Brad Dempsey, who became CEO of the company in July, shared in a statement. "Restructuring for long-term viability requires managers to make very difficult business decisions that affect people and business partners, and we intend to do what we can to minimize these impacts."

Tattered Cover intends to honor all gift cards. All of its changes and decisions require the approval of the bankruptcy court.  

Read More

Continue Reading

Government

Texas A&M receives over $1 million in USDA grants to study SARS-CoV-2 in deer

Texas A&M University scientists and research partners have received two National Institute of Food and Agriculture (NIFA) Agriculture and Food Research…

Published

on

Texas A&M University scientists and research partners have received two National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) grants to study the spread of SARS-CoV-2 in deer. These funds will help researchers understand the impact of the virus in Texas’ deer populations and its relationship to human and ecological health.

Credit: Sarah Hamer/Texas A&M University School of Veterinary Medicine and Biomedical Sciences

Texas A&M University scientists and research partners have received two National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) grants to study the spread of SARS-CoV-2 in deer. These funds will help researchers understand the impact of the virus in Texas’ deer populations and its relationship to human and ecological health.

For these projects, the research team will focus on captive deer, which are an agricultural species in Texas, including managed deer that live on large, rural properties enclosed by fences, as well as on the wild deer with which captive deer may interact and deer living in zoos and wildlife centers. 

Understanding The Ecology Of Disease

The first $800,000 USDA grant will fund a multifaceted three-year project designed to help scientists understand how the virus that causes COVID-19 spreads among deer and, for the first time, how the SARS-CoV-2 virus has impacted overall deer health.

What makes the study unique is its focus on understanding disease in the context of whole ecological systems, examining not only how captive deer interact with each other, but also how the diverse wild and captive animal community may interact with the deer. For example, the study will investigate patterns of infection among captive deer, the humans who work with the deer, other domestic livestock on the ranches, as well as wild mammals in the environment.

To do this, researchers at Texas A&M will collaborate with the Deer Research Program at the Texas A&M University-Kingsville’s (TAMUK) Caesar Kleberg Wildlife Research Institute, which will help collect the large number of samples needed for the project.

“The first aim of the project is a screening study (testing the deer for SARS-CoV-2) of 30 ranches, farms, or other managed areas with deer across the state, such as safari-style parks and zoos,” said Dr. Sarah Hamer, professor of epidemiology at the Texas A&M School of Veterinary Medicine & Biomedical Sciences (VMBS) and lead researcher for Texas A&M on both projects. “This stage will allow us to see where there has been deer exposure to the virus in the past and where there are active infections.”

The second stage of the project will focus on locations where coronavirus infections are found in deer.

“If we find infected deer, we will then transition to a phase of the study where we can not only re-sample the deer over time to monitor changes in their infection and health, but also sample other farm animals and native wildlife on each property. We will also sample the people on each ranch who regularly interact with the deer,” Hamer explained. “These will most likely be the workers who are responsible for putting out the feed and water for the animals.”

This broader range of samples will help Hamer and the rest of the team learn more about the transmission of the SARS-CoV-2 virus between animals and people that share an ecological relationship. Their approach to consider humans, animals, and the environment was proposed after Hamer’s teams spent more than two years studying the virus among people and their pet dogs and cats in Centers for Disease Control and Prevention-funded research; that research showed that infections were not uncommon among domestic animals that live in houses with active human cases.

The laboratory analyses for the deer project will be overseen by Dr. Gabriel Hamer, professor in the Texas A&M Department of Entomology. 

“Once we detect positive samples for SARS-CoV-2, we will work with partners to sequence the viral genomes across all of the infected species and see how they compare,” he said. “We want to see if we can infer which direction the infection is spreading among deer, other animals, and humans.”

The final part of the three-year project will analyze how overall deer health has been impacted by the virus. 

“Of all four goals, this one is probably the most important for the deer producers,” said Dr. Walt Cook, a clinical associate professor in the VMBS’ Department of Veterinary Pathobiology and co-investigator on the project. “We want to know if SARS-CoV-2 might affect things like body condition, antler growth, and reproduction.” 

The robust captive cervid industry in Texas makes this an ideal state for better understanding how and when the virus infects deer. In comparison to tracking wild deer, the opportunity to study deer belonging to managed herds will allow researchers to answer many of the unknown questions about SARS-CoV-2 and deer health. 

“Most of the existing studies on wild deer rely on hunter-harvested samples,” Sarah Hamer said. “A deer may test positive for a SARS-CoV-2 infection, but at that point, the body has been processed and we can’t know its symptoms or if the virus impacted the deer’s health or fitness in any way.”

“We’re extremely appreciative that producers across the state are allowing us to study their herds so that we can better understand how SARS-CoV-2 is maintained in nature,” Cook said. “We have the opportunity to study the ecology of the disease in real settings across the state to learn about what these animals may be exposed to, while maintaining anonymity (with no information regarding specific test results, locations of properties, or premise ownership being released publicly or to any agency), to benefit us all in the future.”

Because of the project’s unique scope and complexity, the researchers hope to answer questions relating SARS-CoV-2 to many different aspects of human, animal, and environmental health.

“For the last three years, zoonotic disease has brought the world to a halt and impacted virtually every aspect of life on earth,” said Dr. Michael Cherry, a white-tailed deer expert at TAMUK and partner on the projects. “Understanding the ecology of these diseases and how they affect human health, food security, and important sectors of the economy will make us better prepared for future zoonotic outbreaks.”

“The diverse team is one of the unique aspects of this ambitious project,” Cherry said. “Dr. Hamer has pulled together a fantastic team, and I’m happy to be able to contribute.”

Protecting Against Future Outbreaks

The second project, funded by a $650,000 USDA grant and spearheaded by biotech company Ginkgo Bioworks, will include sequencing the RNA of SARS-CoV-2 found in white-tailed deer to better understand which strains are active in deer populations and to track possible mutations so that we can better protect ourselves from future outbreaks of the virus in the human population. 

“Zoonotic research like this is key to helping make informed decisions and avoid future outbreaks,” said Matt McKnight, general manager of biosecurity at Ginkgo Bioworks. “This data and research will provide governments, industry leaders, and academics the information they need to optimize behaviors and provide early warnings to prevent disease spillover.”

The first part of the project entails sampling and testing deer to see if they carry SARS-CoV-2. Once the researchers have the positive samples, they can begin sequencing genomes from the virus samples.

“Our group at Texas A&M will be responsible for working with collaborators to collect samples from deer,” Hamer said. “We’ll also be responsible for the initial screening for SARS-CoV-2. If we find positive samples, we ship them to Ginkgo and they’ll work to sequence the virus and analyze how the sequences compare to those found by others.”

In order to reach the sample size goals for the project, the researchers also are collaborating with the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL) to gather samples from deer lymph nodes.

“TVMDL regularly gets samples from both wild and captive deer for chronic wasting disease (CWD) testing,” said Carlos Rodriguez, TVMDL epidemiologist. “The samples often come from hunter-harvested deer, and we are able to repurpose the remaining tissue to contribute to this COVID project.”

Because COVID-19 is resurgent in the human population, projects like this one are important given that scientists are still uncovering new ways that the disease continues to impact the world.

“The public health protective measures that are available for humans — like vaccines and masks — really aren’t options for deer,” Hamer said. “We’re interested to learn under what conditions deer become infected and how long they can maintain the infection in nature. Of course, we’re also interested to study potential onward transmission from deer to other deer, wildlife, or humans in order to learn how that may contribute to the overall ecology of this virus in nature.”

By Courtney Price, Texas A&M University School of Veterinary Medicine and Biomedical Sciences

###


Read More

Continue Reading

Spread & Containment

Gwangju Institute of Science and Technology scientists develop deep learning-based biosensing platform to count viral particles better

Rapid and on-site diagnostic technologies for identifying and quantifying viruses are essential for planning treatment strategies for infected patients…

Published

on

Rapid and on-site diagnostic technologies for identifying and quantifying viruses are essential for planning treatment strategies for infected patients and preventing further spread of the infection. The COVID-19 pandemic has highlighted the need for accurate yet decentralized diagnostic tests that do not involve complex and time-consuming processes needed for conventional laboratory-based tests.

Credit: Professor Young Min Song from GIST, Korea

Rapid and on-site diagnostic technologies for identifying and quantifying viruses are essential for planning treatment strategies for infected patients and preventing further spread of the infection. The COVID-19 pandemic has highlighted the need for accurate yet decentralized diagnostic tests that do not involve complex and time-consuming processes needed for conventional laboratory-based tests.

A popular point-of-care diagnostic tool for quantifying viral loads is bright-field microscopic imaging. However, the small size (~ 100 nm) and low refractive index (~ 1.5, same as that of a microscope slide) of bioparticles such as viruses often makes their accurate estimation difficult and increases the limit of detection (the lowest concentration of viral load that can be reliably detected). Recent studies have found that Gires-Tournois (GT) biosensors, a type of nanophotonic resonators, can detect minuscule virus particles and produce colorful micrographs (images taken through a microscope) of viral loads. But they suffer from visual artifacts and non-reproducibility, limiting their utilization.

In a recent breakthrough, an international team of researchers, led by Professor Young Min Song from the School of Electrical Engineering and Computer Science at Gwangju Institute of Science and Technology in Korea, has leveraged artificial intelligence (AI) to overcome this problem. Their work was made available online on August 24, 2023 and will be published in Volume 52 of the journal Nano Today in October 01, 2023.

The team proposed a synergistic biosensing tool called “DeepGT,” which can harness the advantages of GT sensing platforms and merge them with deep learning-based algorithms to accurately quantify nanoscale bioparticles, including viruses, without the need for complex sample preparation methods.

We designed DeepGT to objectively assess the severity of an infection or disease. This means that we will no longer have to rely solely on subjective assessments for diagnosis and healthcare but will instead have a more accurate and data-driven approach to guide therapeutic strategies,” explains Prof. Song, revealing the motivation behind their study.

The team designed a GT biosensor with a trilayered thin-film configuration and biofunctionalized it to enable colorimetric sensing upon interaction with target analytes. The sensing abilities were verified by simulating the binding mechanism between host cells and the virus using specially prepared bioparticles that mimicked SARS-CoV-2—the coronavirus strain that caused the COVID-19 pandemic.

Next, the researchers trained a convolutional neural network (CNN) using over a thousand optical and scanning electron micrographs of the GT biosensor surface with different types of nanoparticles. They found that DeepGT was able to refine visual artifacts associated with bright-field microscopy and extract relevant information, even at viral concentrations as low as 138 pg ml–1. Moreover, it determined the bioparticle count with a high accuracy, characterized by a mean absolute error of 2.37 across 1,596 images compared to 13.47 for rule-based algorithms, in under a second. Boosted by the performance of CNNs, the biosensing system can also indicate the severity of the infection from asymptomatic to severe based on the viral load.

DeepGT thus presents an efficient and precise way of screening viruses across a broad size range without being hindered by the minimum diffraction limit in visible light. “Our approach provides a practical solution for the swift detection and management of emerging viral threats as well as the improvement of public health preparedness by potentially reducing the overall burden of costs associated with diagnostics,” concludes Prof. Song.

We too hope that this study will enable new AI-powered healthcare technologies that will improve the quality of life of patients across the globe!

 

***

 

Reference

DOI: https://doi.org/10.1016/j.nantod.2023.101968

 

About the Gwangju Institute of Science and Technology (GIST)

The Gwangju Institute of Science and Technology (GIST) was founded in 1993 by the Korean government as a research-oriented graduate school to help ensure Korea’s continued economic growth and prosperity by developing advanced science and technology with an emphasis on collaboration with the international community. Since that time, GIST has pioneered a highly regarded undergraduate science curriculum in 2010 that has become a model for other science universities in Korea. To learn more about GIST and its exciting opportunities for researchers and students alike, please visit: http://www.gist.ac.kr/.

 

About the Author

Young Min Song is a distinguished professor at the School of Electrical Engineering and Computer Science at Gwangju Institute of Science and Technology (GIST). His research interests encompass advanced optoelectronic sensors, multifunctional nanophotonics, and semiconductor devices. He has published more than 150 peer-reviewed research articles, including contributions to prestigious journals such as Nature, Science, and Nature Electronics. His extensive impact is reflected in his Google Scholar profile, which boasts over 10,000 citations and an h-index of 40. He is also an active editorial board member for several respected journals, including IEEE Photonics Journal and Electronics (MDPI), Micromachines (MDPI), and IJPEM (Springer).


Read More

Continue Reading

Trending